PDCD1 and cancer: Some of the main negative immune checkpoints that are currently being investigated in cancer, chronic viral infections and sepsis include the PD-1/PD-L1/PD-L2 pathway, the TIM-3/Galectin-9 pathway, CTLA-4 and LAG-3.